Vienna Insurance Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Hold |
85,000
| – | – | 0.08% | 88 |
|
|
2025
Q1 | $136K | Hold |
85,000
| – | – | 0.07% | 93 |
|
|
2024
Q4 | $306K | Hold |
85,000
| – | – | 0.18% | 85 |
|
|
2024
Q3 | $485K | Hold |
85,000
| – | – | 0.21% | 91 |
|
|
2024
Q2 | $393K | Hold |
85,000
| – | – | 0.15% | 94 |
|
|
2024
Q1 | $694K | Hold |
85,000
| – | – | 0.27% | 95 |
|
|
2023
Q4 | $480K | Hold |
85,000
| – | – | 0.22% | 91 |
|
|
2023
Q3 | $158K | Hold |
85,000
| – | – | 0.07% | 91 |
|
|
2023
Q2 | $234K | Hold |
85,000
| – | – | 0.11% | 88 |
|
|
2023
Q1 | $267K | Hold |
85,000
| – | – | 0.16% | 88 |
|
|
2022
Q4 | $502K | Hold |
85,000
| – | – | 0.39% | 33 |
|
|
2022
Q3 | $745K | Hold |
85,000
| – | – | 0.53% | 35 |
|
|
2022
Q2 | $641K | Hold |
85,000
| – | – | 0.43% | 36 |
|
|
2022
Q1 | $2.06M | Buy |
85,000
+40,000
| +89% | +$970K | 1.16% | 32 |
|
|
2021
Q4 | $1.45M | Buy |
+45,000
| New | +$1.45M | 0.99% | 28 |
|